PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 1 filers reported holding PROVENTION BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $991,715 | -82.5% | 41,150 | -92.3% | 0.00% | -100.0% |
| Q4 2022 | $5,653,534 | +4650.9% | 534,866 | +1920.4% | 0.00% | – |
| Q3 2022 | $119,000 | +26.6% | 26,473 | +13.0% | 0.00% | – |
| Q2 2022 | $94,000 | -94.3% | 23,419 | -89.7% | 0.00% | – |
| Q1 2022 | $1,659,000 | +1282.5% | 226,708 | +967.2% | 0.00% | – |
| Q4 2021 | $120,000 | -23.6% | 21,244 | -13.8% | 0.00% | – |
| Q3 2021 | $157,000 | -16.9% | 24,658 | +10.4% | 0.00% | – |
| Q2 2021 | $189,000 | +23.5% | 22,345 | +53.3% | 0.00% | – |
| Q1 2021 | $153,000 | -97.4% | 14,576 | -95.7% | 0.00% | -100.0% |
| Q4 2020 | $5,790,000 | +24.4% | 341,823 | -5.8% | 0.00% | 0.0% |
| Q3 2020 | $4,653,000 | -21.8% | 362,703 | -14.0% | 0.00% | 0.0% |
| Q2 2020 | $5,949,000 | +27.4% | 421,619 | -16.9% | 0.00% | 0.0% |
| Q1 2020 | $4,669,000 | +104.9% | 507,485 | +231.8% | 0.00% | +100.0% |
| Q4 2019 | $2,279,000 | – | 152,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |